Our unique and proprietary platform technology - Organelle(Chloroplast and Mitochondria) gene editing - enables us to edit RuBisCo, a key enzyme in photosynthesis and the most abundant protein in the world. We believe that our research and vision can lead to the ultimate key solution for climate crisis and food scarcity.
Company Details
- Employees
- 10
- Founded
- 2022
- Address
- 1204-1206, 219, Gasan Digital 1-Ro, Geumcheon-Gu,, Seoul,08501,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://greengeneinc.com/
- Keywords
- 엽록체교정, 미토콘드리아교정, 제초제저항, 잔디, 광합성효율개선, 식물DNA편집, 작물생산량향상, Chloroplast gene editing, Mitochondrial gene editing, Turfgrass, RuBisCo editing, Enhancing photosynthesis.
- HQ
- Seoul
Greengene Questions
Greengene's website is https://greengeneinc.com/
Greengene's LinkedIn profile is https://kr.linkedin.com/company/greengene
Greengene has
10 employees.
View email and phone details for 10
employees at Greengene.
Greengene's industry is
Biotechnology Research
Greengene's top competitors are
Biofuture Medicine,
Nanobrick Bio Group,
Arrow Diagnostics S.r.l.,
And Biologicals Bv,
Eurospital Spa,
Liondx Srl,
Solink Srl,
Ab Analitica,
Sise Global Service,
Toolgen Inc..
Greengene's categories are Biotechnology Research
Greengene's founding year is 2022
